Background To date there is no therapy consensus in patients with multifocal hepatocellular
carcinoma (mHCC). Purpose To compare outcome of trans-arterial chemoembolization …

Objective: The aims of this study were to: a) evaluate tumor response rates using modified-
Response-evaluation-criteria-in-solid-tumors (mRecist) criteria, b) evaluate safety of …

Purpose To evaluate safety and efficacy of degradable starch microspheres (DSMs) TACE in
a large clinical cohort of patients with unresectable HCC. Materials and methods This is a …

Purpose To evalutate safety and efficacy of degradable starch microspheres (DSM) as
embolic agent in transarterial chemoembolisation (TACE) of unresectable, locally extensive …

Purpose To analyze tumor response, survival and safety in patients with non-resectable
hepatocellular carcinoma (HCC) treated with transarterial hepatic chemoembolization using …

Results: No significant difference was noted between the two groups in terms of local
recurrence (31.6 vs. 16.7%) or mortality (73.9 vs. 85.7%) rates after 36-month and 12-month …

Background A common treatment strategy for individuals with multifocal hepatocellular
carcinoma (HCC) who are not candidates for surgical resection is transarterial …

The role of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC)
management has changed over the last twenty years. There has been a trend towards an …

Background To evaluate survival data and local tumor control after transarterial
chemoembolization in two groups with different embolization protocols for the treatment of …

Purpose To compare transarterial chemoembolization delivered with drug eluting beads
(TACE-DEB) with stereotactioc body radiation therapy (SBRT) in patients with hepatocellular …